Hassan Ashktorab to Liver Neoplasms
This is a "connection" page, showing publications Hassan Ashktorab has written about Liver Neoplasms.
Connection Strength
1.699
-
Brim H, Gonzales S, Deverapalli M, Laiyemo AO, Rashid M, Zafar R, Nembhard C, Ashktorab H. Advanced-stage colorectal cancer in the context of coronavirus disease-19, highlighting socioeconomic disparities and outcomes: a case report. J Med Case Rep. 2025 Sep 29; 19(1):467.
Score: 0.762
-
Sherif ZA, Nouraie SM, Lee E, Aduli F, Brim H, Ashktorab H. Trends in the Incidence of Hepatocellular Carcinoma in Washington DC: A Single Institutional Cohort Study (1959-2013). J Natl Med Assoc. 2021 Aug; 113(4):396-404.
Score: 0.555
-
Singh A, Gupta I, Saha P, Hole A, Anthony F, Natu A, Smoot DT, Ashktorab H, Chilakapati MK, Gupta S. Raman spectroscopy for detecting gastric and liver cancer cells that entered a tolerant persistence state to survive cisplatin chemotherapy. Biochem Biophys Res Commun. 2025 11 19; 790:152891.
Score: 0.192
-
Singh A, Natu A, Anthony F, Muthu H, Khade B, Smoot DT, Ashktorab H, Gupta S. The synergistic action of HDAC inhibitor with cisplatin impedes survival and proliferation of drug-tolerant persister in gastric and liver cancer cells. Clin Epigenetics. 2025 Oct 08; 17(1):168.
Score: 0.191